Psychosocial Factors Affecting Medication Adherence Among HIV-1 Infected Adults Receiving Combination Antiretroviral Therapy (cART) in Botswana
- 1 June 2010
- journal article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 26 (6) , 685-691
Abstract
As increasing numbers of persons are placed on potentially life-saving combination antiretroviral therapy (cART) in sub-Saharan Africa, it is imperative to identify the psychosocial and social factors that may influence antiretroviral (ARV) medication adherence. Using an 87 question survey, the following data were collected from patients on cART in Botswana: demographics, performance (Karnofsky) score, perceived stigma and level of HIV disclosure, attitudes and beliefs concerning HIV/AIDS, substance and/or drug use, depression, and pharmacy and healthcare provider-related factors. Overall adherence rates were determined by patient self-report, institutional adherence, and a culturally modified Morisky scale. Three hundred adult patients were recruited between April and May 2005. The overall cART adherence rate was 81.3% based on 4 day and 1 month patient recall and on clinic attendance for ARV medication refills during the previous 3 months. Adults receiving cART for 1-6 months were the least adherent (77%) followed by those receiving cART for greater than 12 months (79%). Alcohol use, depression, and nondisclosure of positive HIV status to their partner were predictive of poor adherence rates (p value <0.02). A significant proportion (81.3%) of cART-treated adults were adherent to their prescribed treatment, with rates superior to those reported in resource-rich settings. Adherence rates were poorest among those just starting cART, most likely due to the presence of ARV-related toxicity. Adherence was lower among those who have been treated for longer periods of time (greater than 1 year), suggesting complacency, which may become a significant problem, especially among these long-term cART-treated patients who return to improved physical and mental functioning and may be less motivated to adhere to their ARV medications. Healthcare providers should encourage HIV disclosure to "at-risk" partners and provide ongoing counseling and education to help patients recognize and overcome HIV-associated stigma, alcohol abuse, and depression.Keywords
This publication has 32 references indexed in Scilit:
- Explaining Adherence Success in Sub-Saharan Africa: An Ethnographic StudyPLOS Medicine, 2009
- Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in AfricaAIDS Care, 2007
- Psychosocial Mediators of Antiretroviral Nonadherence in HIV-Positive Adults With Substance Use and Mental Health Problems.Health Psychology, 2004
- Strategies for Optimizing Adherence to Highly Active Antiretroviral Therapy: Lessons from Research and Clinical PracticeClinical Infectious Diseases, 2001
- Valuation of EuroQOL (EQ-5D) Health States in an Adult US SamplePharmacoEconomics, 1998
- Credit programs, patriarchy and men's violence against women in rural BangladeshSocial Science & Medicine, 1996
- Depressive Symptoms in Patients with HIV InfectionAustralian & New Zealand Journal of Psychiatry, 1996
- Transmission of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Variants Following Deliberate Injection of Blood from a Patient with AIDS: Characteristics and Natural History of the VirusClinical Infectious Diseases, 1995
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948